Accelerating Implementation of Long-Acting Injectables
RWHAP Technical Assistance Provider updated on 07/09/2024
RWHAP Technical Assistance Provider updated on 07/09/2024
Blog updated 03/28/2024
RWHAP Technical Assistance Provider updated on 03/04/2024
Resource updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
We conducted semi-structured interviews with service providers to investigate current barriers, potential opportunities, estimated costs, and anticipated outcomes of program expansion for food, financial, transportation, and housing support services for RWHAP clients.
Resource (Conference Presentation) updated 09/14/2023
We used a data-driven, mixed method approach to develop a community planning and budget tool to inform resource allocation decision-making to achieve health equity in HIV outcomes among RWHAP clients in the Minneapolis-St. Paul Transitional Grant Area.
Resource (Conference Presentation) updated 09/14/2023
Review of data on delivery of rapid start of ART among New Jersey providers, including, for example, provision of same-day medical appointments, extended office hours, and comfort administering rapid start with high need patients.
Resource (Conference Presentation) updated 12/11/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Review of rapid ART features to reduce time to ART from 7 to 1.6 days, including pre-visit benefits navigation, manufacturer discount cards, prescribing to in-house pharmacies, email distribution lists, and post-prescriptive follow-up.
Resource (Conference Presentation) updated 09/14/2023
The COVID-19 public health emergency (PHE) exacerbated homelessness and housing instability. NY EMA Planning staff worked collaboratively to address homelessness as a driving force of poorer health outcomes for people living with HIV. This presentation will illustrate community planning processes for addressing housing-related barriers among RWHAP consumers during the PHE.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Harris Health System began its Rapid Eligibility and ART Dissemination & Implementation (READI) program in 2019. Here, we present two years of data that examine linkage to care, ART initiation, viral loads, completion of medical visits, and demographics for patients who received READI services and those who did not.
Resource (Conference Presentation) updated 09/14/2023
Overview of HRSA HAB work to develop three electronic clinical quality measures (eCQMs) focused on HIV care.
Resource (Conference Presentation) updated 09/14/2023
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023